This is probably why in the majority of studies of ferrotherapy and HF, the predominant stages are 2 and 3 [20,22,27], as patients in more advanced stages are usually in a situation of frank anaemia, usually suffer from a deficiency in the production of erythropoietin, and require more intensive treatment and specific management [26,28]. This evidence concerns the gene EPO and anemia.